Literature DB >> 30190268

SPLUNC1 degradation by the cystic fibrosis mucosal environment drives airway surface liquid dehydration.

Megan J Webster1, Boris Reidel1, Chong D Tan1, Arunava Ghosh1, Neil E Alexis2, Scott H Donaldson1,3, Mehmet Kesimer1, Carla M P Ribeiro1,4, Robert Tarran5,4.   

Abstract

The multi-organ disease cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane regulator gene (CFTR) that lead to diminished transepithelial anion transport. CF lungs are characterised by airway surface liquid (ASL) dehydration, chronic infection/inflammation and neutrophilia. Dysfunctional CFTR may upregulate the epithelial Na+ channel (ENaC), further exacerbating dehydration. We previously demonstrated that short palate lung and nasal epithelial clone 1 (SPLUNC1) negatively regulates ENaC in normal airway epithelia.Here, we used pulmonary tissue samples, sputum and human bronchial epithelial cells (HBECs) to determine whether SPLUNC1 could regulate ENaC in a CF-like environment.We found reduced endogenous SPLUNC1 in CF secretions, and rapid degradation of recombinant SPLUNC1 (rSPLUNC1) by CF secretions. Normal sputum, containing SPLUNC1 and SPLUNC1-derived peptides, inhibited ENaC in both normal and CF HBECs. Conversely, CF sputum activated ENaC, and rSPLUNC1 could not reverse this phenomenon. Additionally, we observed upregulation of ENaC protein levels in human CF bronchi. Unlike SPLUNC1, the novel SPLUNC1-derived peptide SPX-101 resisted protease degradation, bound apically to HBECs, inhibited ENaC and prevented ASL dehydration following extended pre-incubation with CF sputum.Our data indicate that CF mucosal secretions drive ASL hyperabsorption and that protease-resistant peptides, e.g. SPX-101, can reverse this effect to rehydrate CF ASL.
Copyright ©ERS 2018.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30190268      PMCID: PMC6547379          DOI: 10.1183/13993003.00668-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  43 in total

1.  The first-nucleotide binding domain of the cystic-fibrosis transmembrane conductance regulator is important for inhibition of the epithelial Na+ channel.

Authors:  R Schreiber; A Hopf; M Mall; R Greger; K Kunzelmann
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis.

Authors:  Scott D Sagel; Marci K Sontag; Jeffrey S Wagener; Robert K Kapsner; Iris Osberg; Frank J Accurso
Journal:  J Pediatr       Date:  2002-12       Impact factor: 4.406

3.  Potential difference measurements in the lower airway of children with and without cystic fibrosis.

Authors:  Jane C Davies; Michael Davies; Donna McShane; Stephen Smith; Sharon Chadwick; Adam Jaffe; Raymond Farley; Louise Collins; Andrew Bush; Michael Scallon; John Pepper; Duncan M Geddes; Eric W F W Alton
Journal:  Am J Respir Crit Care Med       Date:  2005-01-07       Impact factor: 21.405

4.  Universal sample preparation method for proteome analysis.

Authors:  Jacek R Wiśniewski; Alexandre Zougman; Nagarjuna Nagaraj; Matthias Mann
Journal:  Nat Methods       Date:  2009-04-19       Impact factor: 28.547

5.  Regulation of endogenous ENaC functional expression by CFTR and ΔF508-CFTR in airway epithelial cells.

Authors:  Ronald C Rubenstein; Shannon R Lockwood; Ellen Lide; Rebecca Bauer; Laurence Suaud; Yael Grumbach
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-10-08       Impact factor: 5.464

6.  Neutrophil elastase activates near-silent epithelial Na+ channels and increases airway epithelial Na+ transport.

Authors:  Ray A Caldwell; Richard C Boucher; M Jackson Stutts
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-01-07       Impact factor: 5.464

7.  Association of airway cathepsin B and S with inflammation in cystic fibrosis.

Authors:  S L Martin; K L Moffitt; A McDowell; C Greenan; R J Bright-Thomas; A M Jones; A K Webb; J S Elborn
Journal:  Pediatr Pulmonol       Date:  2010-09

8.  Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth.

Authors:  David A Stoltz; David K Meyerholz; Alejandro A Pezzulo; Shyam Ramachandran; Mark P Rogan; Greg J Davis; Robert A Hanfland; Chris Wohlford-Lenane; Cassie L Dohrn; Jennifer A Bartlett; George A Nelson; Eugene H Chang; Peter J Taft; Paula S Ludwig; Mira Estin; Emma E Hornick; Janice L Launspach; Melissa Samuel; Tatiana Rokhlina; Philip H Karp; Lynda S Ostedgaard; Aliye Uc; Timothy D Starner; Alexander R Horswill; Kim A Brogden; Randall S Prather; Sandra S Richter; Joel Shilyansky; Paul B McCray; Joseph Zabner; Michael J Welsh
Journal:  Sci Transl Med       Date:  2010-04-28       Impact factor: 17.956

9.  Soluble mediators, not cilia, determine airway surface liquid volume in normal and cystic fibrosis superficial airway epithelia.

Authors:  Robert Tarran; Laura Trout; Scott H Donaldson; Richard C Boucher
Journal:  J Gen Physiol       Date:  2006-05       Impact factor: 4.086

10.  Tracheobronchial air-liquid interface cell culture: a model for innate mucosal defense of the upper airways?

Authors:  Mehmet Kesimer; Sara Kirkham; Raymond J Pickles; Ashley G Henderson; Neil E Alexis; Genevieve Demaria; David Knight; David J Thornton; John K Sheehan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-10-17       Impact factor: 5.464

View more
  10 in total

1.  SPLUNC1 Loses Its Antimicrobial Activity in Acidic Cystic Fibrosis Airway Secretions.

Authors:  Saira Ahmad; Rodney C Gilmore; Neil E Alexis; Robert Tarran
Journal:  Am J Respir Crit Care Med       Date:  2019-09-01       Impact factor: 21.405

2.  Thickness of the airway surface liquid layer in the lung is affected in cystic fibrosis by compromised synergistic regulation of the ENaC ion channel.

Authors:  Daniel V Olivença; Luis L Fonseca; Eberhard O Voit; Francisco R Pinto
Journal:  J R Soc Interface       Date:  2019-08-28       Impact factor: 4.118

3.  SPLUNC1 is a negative regulator of the Orai1 Ca2+ channel.

Authors:  Tongde Wu; Alexandra S Goriounova; Erin N Worthington; Joe A Wrennall; Arunava Ghosh; Saira Ahmad; M Flori Sassano; Robert Tarran
Journal:  Physiol Rep       Date:  2022-05

Review 4.  E-cigarettes, nicotine, the lung and the brain: multi-level cascading pathophysiology.

Authors:  Melissa Herman; Robert Tarran
Journal:  J Physiol       Date:  2020-07-06       Impact factor: 5.182

Review 5.  Mucus, mucins, and cystic fibrosis.

Authors:  Cameron Bradley Morrison; Matthew Raymond Markovetz; Camille Ehre
Journal:  Pediatr Pulmonol       Date:  2019-11

6.  ENaC regulation by phospholipids and DGK explained through mathematical modeling.

Authors:  Daniel V Olivença; Eberhard O Voit; Francisco R Pinto
Journal:  Sci Rep       Date:  2020-08-18       Impact factor: 4.379

7.  SPLUNC1: a novel marker of cystic fibrosis exacerbations.

Authors:  Sara Khanal; Megan Webster; Naiqian Niu; Jana Zielonka; Myra Nunez; Geoffrey Chupp; Martin D Slade; Lauren Cohn; Maor Sauler; Jose L Gomez; Robert Tarran; Lokesh Sharma; Charles S Dela Cruz; Marie Egan; Theresa Laguna; Clemente J Britto
Journal:  Eur Respir J       Date:  2021-11-11       Impact factor: 33.795

8.  The SPLUNC1-βENaC complex prevents Burkholderia cenocepacia invasion in normal airway epithelia.

Authors:  Saira Ahmad; Christine Seul Ki Kim; Robert Tarran
Journal:  Respir Res       Date:  2020-07-17

9.  Culture with apically applied healthy or disease sputum alters the airway surface liquid proteome and ion transport across human bronchial epithelial cells.

Authors:  Maximillian Woodall; Boris Reidel; Mehmet Kesimer; Robert Tarran; Deborah L Baines
Journal:  Am J Physiol Cell Physiol       Date:  2021-10-06       Impact factor: 4.249

Review 10.  Extracellular Vesicles as Mediators of Cellular Cross Talk in the Lung Microenvironment.

Authors:  Sabine Bartel; Jessy Deshane; Tom Wilkinson; Susanne Gabrielsson
Journal:  Front Med (Lausanne)       Date:  2020-08-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.